Insider Trades - MPM BIOVENTURES III QP LP

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

MPM BIOVENTURES III QP LP: Declared Holdings
Company/Relationship	Reported	Shares	Ownership
ARYx Therapeutics, Inc. Beneficial Owner (10% or more) NasdaqGM:ARYX (historical quotes, profile, other insiders)	14-Nov-08	5,364,572	Indirect
EnteroMedics Inc. Beneficial Owner (10% or more) NasdaqGM:ETRM (historical quotes, profile, other insiders)	24-Feb-09	5,790,841	Indirect
Somaxon Pharmaceuticals, Inc. Beneficial Owner (10% or more) NasdaqCM:SOMX (historical quotes, profile, other insiders)	8-Jul-09	4,632,562	Indirect
Pharmasset, Inc. Beneficial Owner (10% or more) NasdaqGM:VRUS (historical quotes, profile, other insiders)	8-Feb-08	4,061	Indirect

Insider & restricted shareholder transactions reported over the last two years
Date Shares Stock Transaction
8-Jul-09 *1,276,593 SOMX Purchase at $1.05 per share.
(Cost of $1,340,422)
24-Feb-09 *1,765,499 ETRM Purchase at $1.15 per share.
(Cost of $2,030,323)
14-Nov-08 *1,787,710 ARYX Purchase at $2.20 per share.
(Cost of $3,932,962)
8-Feb-08 *6,874 VRUS Sale at $21.36 per share.
(Proceeds of $146,828)
7-Feb-08 *17,450 VRUS Sale at $23.02 per share.
(Proceeds of $401,699)
4-Feb-08 *100,673 VRUS Acquisition (Non Open Market) at $0 per share.
4-Feb-08 *12,993 VRUS Sale at $23.86 per share.
(Proceeds of $310,012)
4-Feb-08 *713,912 VRUS Disposition (Non Open Market) at $0 per share.

* Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.
Questions or Comments?

Insider & restricted shareholder transactions reported over the last two years
Date	Shares	Stock	Transaction
8-Jul-09	*1,276,593	SOMX	Purchase at $1.05 per share. (Cost of $1,340,422)
24-Feb-09	*1,765,499	ETRM	Purchase at $1.15 per share. (Cost of $2,030,323)
14-Nov-08	*1,787,710	ARYX	Purchase at $2.20 per share. (Cost of $3,932,962)
8-Feb-08	*6,874	VRUS	Sale at $21.36 per share. (Proceeds of $146,828)
7-Feb-08	*17,450	VRUS	Sale at $23.02 per share. (Proceeds of $401,699)
4-Feb-08	*100,673	VRUS	Acquisition (Non Open Market) at $0 per share.
4-Feb-08	*12,993	VRUS	Sale at $23.86 per share. (Proceeds of $310,012)
4-Feb-08	*713,912	VRUS	Disposition (Non Open Market) at $0 per share.